ResearcherNanjing Drum Tower HospitalNo recent work listed

Zhong-Min Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7649-3233; OpenAlex author ID A5100751415. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/jcp.30346 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bingyan Liu · 1 shared paper, 2021 · strength 0.13
- Paper TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adeno… DOI 10.1002/jcp.30346 ↗
Aiwu Mao · 1 shared paper, 2021 · strength 0.13
- Paper TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adeno… DOI 10.1002/jcp.30346 ↗
Mingyi Shang · 1 shared paper, 2021 · strength 0.13
- Paper TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adeno… DOI 10.1002/jcp.30346 ↗
Xiaoping Zou · 1 shared paper, 2021 · strength 0.13
- Paper TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adeno… DOI 10.1002/jcp.30346 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.